Episode #12: Trust in the Pharma Industry has been saved
Episode #12: Trust in the Pharma Industry
Life Sciences Connect
In our twelfth episode of the Life Science Connect podcast series, we explore the public perception of trust in the pharma industry. We discuss the results from the research report Overcoming biopharma’s trust deficit: Why people mistrust the biopharma industry, as well as how COVID-19 has affected these perceptions and how the industry might improve diversity of clinical trials by improving trust.
Welcome to “Life Sciences Connect”, Deloitte’s Podcast on the Life Sciences industry. This series features conversations with leaders from across the Healthcare ecosystem sharing their insights on the critical issues facing the industry today.
In January 2021, Deloitte’s US and UK Centres for Health Solutions conducted consumer research in the US, UK, India and South Africa seeking to answer crucial questions around consumer trust in pharma, culminating in our research report Overcoming biopharma’s trust deficit: Why people mistrust the biopharma industry – and what to do about it. In today’s conversation, we are discussing how trust impacts biopharma and how companies can build and maintain consumer trust.
Find out more
If you are interested in any of the topics discussed during this episode, please find useful links below:
- Stay up to date on industry issues by subscribing to our blog.